Buy Breakdown
Total $0
No buy transactions for this time period.
Sell Breakdown
Total $13,644,367
Monthly Totals
| Transaction | Filed | Name | Type | Shares @ Price | Value | Balance change | Ownership | |
|---|---|---|---|---|---|---|---|---|
|
03/04/2025
10b5-1
|
03/05/2025 |
CSO & EVP, Head of Research
Officer
|
Sell
|
-844 @ $241.15
|
($203,531.99)
|
13,501 | (-5.88%) | Direct |
|
03/04/2025
10b5-1
|
03/05/2025 |
CMO & EVP Dev & Med Affairs
Officer
|
Sell
|
-808 @ $241.05
|
($194,766.11)
|
24,542 | (-3.19%) | Direct |
|
03/03/2025
10b5-1
|
03/05/2025 |
CSO & EVP, Head of Research
Officer
|
Sell
|
-1,911 @ $243.73
|
($465,772.08)
|
14,345 | (-11.76%) | Direct |
|
03/03/2025
10b5-1
|
03/05/2025 |
CMO & EVP Dev & Med Affairs
Officer
|
Sell
|
-1,749 @ $243.79
|
($426,384.29)
|
25,350 | (-6.45%) | Direct |
|
03/03/2025
|
03/05/2025 |
Chief Executive Officer
CEO
Director
|
Sell
|
-3,877 @ $243.79
|
($945,164.88)
|
98,635 | (-3.78%) | Direct |
|
03/03/2025
|
03/05/2025 |
EVP, Chief Financial Officer
CFO
|
Sell
|
-1,264 @ $243.78
|
($308,140.61)
|
47,751 | (-2.58%) | Direct |
|
03/03/2025
|
03/05/2025 |
EVP, Chief Commercial Officer
Officer
|
Sell
|
-471 @ $243.78
|
($114,820.42)
|
28,011 | (-1.65%) | Direct |
|
02/28/2025
|
03/03/2025 |
CSO & EVP, Head of Research
Officer
|
Sell
|
-496 @ $241.69
|
($119,877.91)
|
12,385 | (-3.85%) | Direct |
|
02/18/2025
10b5-1
|
02/18/2025 |
CSO & EVP, Head of Research
Officer
|
Sell
|
-1,440 @ $251.56
|
($362,243.40)
|
12,881 | (-10.06%) | Direct |
|
02/18/2025
10b5-1
|
02/18/2025 |
CMO & EVP Dev & Med Affairs
Officer
|
Sell
|
-1,548 @ $251.67
|
($389,579.28)
|
11,989 | (-11.44%) | Direct |
|
02/14/2025
|
02/18/2025 |
CSO & EVP, Head of Research
Officer
|
Sell
|
-663 @ $255.21
|
($169,204.39)
|
14,321 | (-4.42%) | Direct |
|
02/14/2025
|
02/18/2025 |
CMO & EVP Dev & Med Affairs
Officer
|
Sell
|
-1,561 @ $255.17
|
($398,324.87)
|
13,537 | (-10.34%) | Direct |
|
02/14/2025
|
02/18/2025 |
Chief Executive Officer
CEO
Director
|
Sell
|
-1,213 @ $255.17
|
($309,526.58)
|
81,526 | (-1.47%) | Direct |
|
02/14/2025
|
02/18/2025 |
EVP, Chief Financial Officer
CFO
|
Sell
|
-967 @ $255.17
|
($246,749.79)
|
32,786 | (-2.86%) | Direct |
|
12/12/2024
10b5-1
|
12/13/2024 |
CMO & EVP Dev & Med Affairs
Officer
|
Sell
|
-1,752 @ $251.00
|
($439,759.94)
|
15,705 | (-10.04%) | Direct |
|
11/27/2024
10b5-1
|
11/27/2024 |
CSO & EVP, Head of Research
Officer
|
Sell
|
-1,531 @ $252.29
|
($386,260.68)
|
12,881 | (-10.62%) | Direct |
|
11/26/2024
|
11/27/2024 |
CSO & EVP, Head of Research
Officer
|
Sell
|
-1,469 @ $250.98
|
($368,685.86)
|
14,412 | (-9.25%) | Direct |
|
11/26/2024
|
11/27/2024 |
CMO & EVP Dev & Med Affairs
Officer
|
Sell
|
-1,682 @ $250.98
|
($422,144.31)
|
17,457 | (-8.79%) | Direct |
|
11/26/2024
|
11/27/2024 |
Chief Executive Officer
CEO
Director
|
Sell
|
-5,219 @ $250.98
|
($1,309,852.75)
|
78,880 | (-6.21%) | Direct |
|
11/26/2024
|
11/27/2024 |
EVP, Chief Financial Officer
CFO
|
Sell
|
-1,682 @ $250.98
|
($422,144.31)
|
30,644 | (-5.20%) | Direct |
|
11/26/2024
|
11/27/2024 |
EVP, Chief Commercial Officer
Officer
|
Sell
|
-1,469 @ $250.98
|
($368,685.86)
|
13,191 | (-10.02%) | Direct |
|
07/11/2024
10b5-1
|
07/12/2024 |
Chief Executive Officer
CEO
Director
|
Sell
|
-7,093 @ $261.00
|
($1,851,273.00)
|
73,441 | (-8.81%) | Direct |
|
06/25/2024
|
06/26/2024 |
CSO & EVP, Head of Research
Officer
|
Sell
|
-1,198 @ $230.99
|
($276,730.75)
|
14,181 | (-7.79%) | Direct |
|
06/25/2024
|
06/26/2024 |
CMO & EVP Dev & Med Affairs
Officer
|
Sell
|
-2,103 @ $230.99
|
($485,773.38)
|
15,609 | (-11.87%) | Direct |
|
06/25/2024
|
06/26/2024 |
Chief Executive Officer
CEO
Director
|
Sell
|
-8,301 @ $230.99
|
($1,917,475.08)
|
80,534 | (-9.34%) | Direct |
|
06/25/2024
|
06/26/2024 |
EVP, Chief Financial Officer
CFO
|
Sell
|
-1,605 @ $231.00
|
($370,747.09)
|
28,892 | (-5.26%) | Direct |
|
06/25/2024
|
06/26/2024 |
EVP, Chief Commercial Officer
Officer
|
Sell
|
-1,605 @ $231.00
|
($370,747.09)
|
11,660 | (-12.10%) | Direct |